Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinson’s Disease Under Rapid Response Innovation Awards 2008

July 29, 2008

Gene silencing techniques and induced pluripotent stem cell technology are among the cutting-edge approaches to Parkinson’s drug development funded through The Michael J. Fox Foundation’s Rapid Response Innovation Awards 2008. (MarketWatch)

Posted by

Posted in General Bioethics, News, Stem Cell Research

Ad